Eco R1 Capital, LLC Rubius Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$3.74 - $9.84 $1.97 Million - $5.17 Million	-525,877 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.23 - $14.12 $1.92 Million - $3.75 Million	265,725 Added 102.14%	525,877 $5 Million
Q3 2019 Nov 14, 2019	SELL	$7.85 - $15.75 $1.59 Million - $3.2 Million	-203,000 Reduced 43.83%	260,152 $2.04 Million
Q2 2019 Aug 14, 2019	SELL	$13.5 - $19.94 $2.47 Million - $3.65 Million	-183,076 Reduced 28.33%	463,152 $7.29 Million
Q1 2019 May 15, 2019	BUY	$13.27 - $18.51 $717,907 - $1 Million	54,100 Added 9.14%	646,228 $11.7 Million
Q3 2018 Nov 14, 2018	BUY	$20.06 - $26.94 $11.9 Million - $16 Million	592,128 New	592,128 $14.2 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.